Effect of preeclampsia and intrauterine growth restriction on endothelial progenitor cells in human umbilical cord blood

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 11, 2012, Pages 2385-2389

  Monga, Ranjan ^a,b   Buck, Steven ^a   Sharma, Priyankar ^a   Thomas, Ronald ^a   Chouthai, Nitin S ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b HURLEY MEDICAL CENTER   (United States)

Author keywords

Endothelial progenitor cells; Human umbilical cord blood; Intrauterine growth restriction; Preeclampsia; Premature birth

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ARTICLE; BIRTH WEIGHT; CELL POPULATION; CELL TYPE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MONONUCLEAR CELL; NEWBORN; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; FETAL BLOOD; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; STEM CELLS; TERM BIRTH;

EID: 84867503558     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.697228     Document Type: Article

References (39)

1. Lin Y, Weisdorf DJ, Solovey A, Hebbel R P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-77. (Pubitemid 30036389)
2. Dignat-George F, Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol 2000;65:215-220.
3. Dignat-George F, Blann A, Sampol J. Circulating endothelial cells in acute coronary syndromes. Blood 2000;95:728. (Pubitemid 30041698)
4. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000;97:3422-3427. (Pubitemid 30183318)
5. Dimmeler S. Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance. Arterioscler Thromb Vasc Biol 2010;30:1088-1093.
6. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28:1584-1595.
7. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003;23:1185-1189. (Pubitemid 36871271)
8. Leone AM, Valgimigli M, Giannico MB, Zaccone V, Perfetti M, D'Amario D, Rebuzzi AG, Crea F. From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. Eur Heart J 2009;30:890-899.
9. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-958. (Pubitemid 30062717)
10. Timmermans F, Plum J, Yöder MC, Ingram DA, Vandekerckhove B, Case J. Endothelial progenitor cells: identity defined? J Cell Mol Med 2009;13:87-102.
11. Meister B, Tötsch M, Mayr A, Widschwendter M, Huter O, Sperl W. Identification of CD34+ cord blood cells and their subpopulations in preterm and term neonates using three-color flow cytometry. Biol Neonate 1994;66:272-279.
12. Fritsch G, Stimpfl M, Kurz M, Printz D, Buchinger P, Fischmeister G, Hoecker P, Gadner H. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Bone Marrow Transplant 1996;17:169-178. (Pubitemid 26057303)
13. Baker CD, Ryan SL, Ingram DA, Seedorf GJ, Abman SH, Balasubramaniam V. Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia. Am J Respir Crit Care Med 2009;180:454-461.
14. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972;1:177-191.
15. Luppi P, Powers RW, Verma V, Edmunds L, Plymire D, Hubel CA. Maternal circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia. Reprod Sci 2010;17:643-652.
16. Xia L, Zhou XP, Zhu JH, Xie XD, Zhang H, Wang XX, Chen JZ, Jian S. Decrease and dysfunction of endothelial progenitor cells in umbilical cord blood with maternal pre-eclampsia. J Obstet Gynaecol Res 2007;33:465-474. (Pubitemid 47222725)
17. Sugawara J, Mitsui-Saito M, Hayashi C, Hoshiai T, Senoo M, Chisaka H, Yaegashi N, Okamura K. Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. J Clin Endocrinol Metab 2005;90:5329-5332. (Pubitemid 41262296)
18. Hwang HS, Maeng YS, Park Y W, Koos BJ, Kwon YG, Kim YH. Increased senescence and reduced functional ability of fetal endothelial progenitor cells in pregnancies complicated by preeclampsia without intrauterine growth restriction. Am J Obstet Gynecol 2008;199:259.e1-259.e7.
19. Kwon JY, Maeng YS, Kwon YG, Kim YH, Kang MH, Park YW. Decreased endothelial progenitor cells in umbilical cord blood in severe preeclampsia. Gynecol Obstet Invest 2007;64:103-108.
20. Matsubara K, Abe E, Matsubara Y, Kameda K, Ito M. Circulating endothelial progenitor cells during normal pregnancy and pre-eclampsia. Am J Reprod Immunol 2006;56:79-85.
21. Khong T Y, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049-1059. (Pubitemid 16004866)
22. Todros T, Sciarrone A, Piccoli E, Guiot C, Kaufmann P, Kingdom J. Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction. Obstet Gynecol 1999;93:499-503. (Pubitemid 29147065)
23. Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 2000;92:35-43.
24. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989;2:577-580. (Pubitemid 19216205)
25. Rogers LK, Velten M. Maternal inflammation, growth retardation, and preterm birth: insights into adult cardiovascular disease. Life Sci 2011;89:417-421.
26. Ballard JL, Novak KK, Driver M. A simplified score for assessment of fetal maturation of newly born infants. J Pediatr 1979;95:769-774. (Pubitemid 10228542)
27. Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements - a prospective study. Am J Obstet Gynecol 1985;151:333-337. (Pubitemid 15237550)
28. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002;77:67-75.
29. Gibbs RS, Castillo MS, Rodgers PJ. Management of acute chorioamnionitis. Am J Obstet Gynecol 1980;136:709-713. (Pubitemid 10156258)
30. Yoder MC. Defining human endothelial progenitor cells. J Thromb Haemost 2009;7 Suppl 1:49-52.
31. Fadini G P, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008;197:496-503.
32. Duda DG, Cohen KS, Scadden DT, Jain RK. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007;2:805-810. (Pubitemid 46745577)
33. Javed MJ, Mead LE, Prater D, Bessler WK, Foster D, Case J, Goebel WS, et al. Endothelial colony forming cells and mesenchymal stem cells are enriched at different gestational ages in human umbilical cord blood. Pediatr Res 2008;64:68-73.
34. Ness RB, Hubel CA. Risk for coronary artery disease and morbid preeclampsia: a commentary. Ann Epidemiol 2005;15:726-733. (Pubitemid 41266978)
35. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-683. (Pubitemid 38364626)
36. Calkins K, Devaskar SU. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care 2011;41:158-176.
37. Shmelkov S V, St Clair R, Lyden D, Rafii S. AC133/CD133/Prominin-1. Int J Biochem Cell Biol 2005;37:715-719. (Pubitemid 40202993)
38. Torrente Y, Belicchi M, Sampaolesi M, Pisati F, Meregalli M, D'Antona G, Tonlorenzi R, et al. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 2004;114:182-195. (Pubitemid 39071623)
39. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000;97:14720-14725. (Pubitemid 32016642)